An official website of the United States government
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.
When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.
Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.
Summary: Effective October 1, 2022, this amendment revises the quarterly nursing home supplemental payment, also known as MQIP, for dates of service in the quarter ending December 31, 2022.
Summary: This amendment proposes to continue to make additional payments to nonpublic and county nursing facilities that qualify for supplemental ventilator care and tracheostomy care.
Summary: This amendment proposes to continue funding for multiple classes of inpatient DSH payments and supplemental payments to Medical Assistance enrolled, qualifying inpatient acute care general hospitals.
Summary: This plan amendment updates the physician services alternative payment model (APM) by changing the time-frame for eligible payments that qualify primary care medical providers (PCMP) for the APM, thereby, making the APM code set
timeline prospective and ongoing rather than tied to specific past dates, and pushing the 2021 APM rate adjustments
back from July 1, 2021 to October 1, 2021.
Summary: This SPA has been submitted as related to the Inflation Reduction Act of 2022 temporary, 5-year increase for physician administered biosimilar drugs that will be paid Medicare's Average Sales Price (ASP) plus 8% (rather than plus 6%).
Summary: This SPA terminates the Hemophilia program arrangement with the South Carolina Department of Health and Environment Control Agency, at their request.